US 9610352
Lyophilized viral formulations
granted A61KA61K35/00A61K35/76
Quick answer
US patent 9610352 (Lyophilized viral formulations) held by ONCOLYTICS BIOTECH INC. expires Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ONCOLYTICS BIOTECH INC.
- Grant date
- Tue Apr 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 34
- CPC classes
- A61K, A61K35/00, A61K35/76, A61K35/765, A61K35/768